查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1855844

2025年全球客製化基因檢測市場報告

Customized Genetic Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，客製化基因檢測市場發展迅速，預計將從2024年的121.6億美元成長到2025年的141.3億美元，複合年成長率達16.2%。過去一段時間的成長可歸因於個性化醫療的日益普及、遺傳性疾病病例的增加、基因檢測在腫瘤學和藥物基因組學領域的早期應用、測序技術的進步以及消費者對祖源和直接面對消費者的基因檢測日益成長的興趣。

預計未來幾年，客製化基因檢測市場將快速成長，到2029年市場規模將達255億美元，複合年成長率（CAGR）為15.9%。推動這一成長的主要因素包括：全基因組定序成本的下降、其在預防性醫療保健領域的廣泛應用、政府對基因組研究的支持、人工智慧在基因數據分析中的應用，以及診斷公司和製藥公司在標靶治療合作的加強。預計將出現的關鍵趨勢包括：家用基因檢測套組的普及、對多基因風險評分的日益重視、基於多體學的個人化醫療保健解決方案的構建、基因檢測與基因諮詢服務的結合以及利用區塊鏈技術安全管理基因數據。

客製化基因檢測是一種個人化的基因分析方法，它根據個人的獨特需求（例如病歷、家族健康背景、種族和具體臨床問題）選擇並檢測特定的基因、變異或DNA區域。這種檢測針對與患者病情最相關的基因，從而實現更準確的風險評估、診斷和管理。客製化基因檢測可以幫助識別遺傳疾病、指導治療決策、預防疾病、進行生育規劃，並支持精準醫療等領域的選擇。

客製化基因檢測的主要類型包括預測性檢測、攜帶者檢測、產前/新生兒檢測、診斷性檢測和藥物基因組學檢測。預測性檢測旨在評估個體的遺傳易感性，並在症狀出現前預測其某些遺傳疾病的風險。這種檢測對於晚年發病的疾病尤其重要，有助於早期介入和知情決策。檢測樣本包括唾液、血液和口腔拭子，並採用次世代定序(NGS)、聚合酵素鏈鎖反應(PCR)、微陣列分析和單細胞定序等技術進行分析。其應用領域涵蓋腫瘤學、心血管疾病、神經系統疾病和代謝性疾病等，具體包括預測性檢測、帶因者檢測、產前/新生兒檢測、診斷性檢測和藥物基因組學檢測。

美國在2025年春季突然提高關稅及其引發的貿易摩擦正嚴重衝擊醫療保健產業，尤其是關鍵醫療設備、診斷設備和藥品的供應。醫院和醫療機構面臨進口手術器械、影像設備以及注射器、導管等耗材成本不斷上漲的困境。這些成本的增加加劇了醫療預算的壓力，導致一些醫療機構必須推遲設備升級或將成本轉嫁給患者。此外，原料和零件的關稅也阻礙了必需藥品和醫療設備的生產，造成供應鏈瓶頸。為此，醫療產業正在尋求籌資策略多元化，盡可能促進在地化生產，並積極爭取對緊急醫療產品實施關稅豁免。

本研究報告是商業研究公司（The Business Research Company）全新系列報告的一部分，該系列報告提供客製化基因檢測市場統計數據，包括全球客製化基因檢測行業市場規模、區域佔有率、市場佔有率及競爭對手、詳細的市場細分、市場趨勢和商機，以及在客製化基因檢測行業取得成功所需的數據。這份客製化基因檢測市場研究報告全面概​​述了您所需的一切資訊，並對行業現狀和未來發展趨勢進行了深入分析。

未來幾年，個人化醫療的日益普及預計將推動客製化基因檢測市場的成長。個人化醫療是一種醫療保健方法，它根據每位患者的獨特特徵量身定做治療方案、預防策略和醫療決策。基因組學、蛋白質組學和生物標記發現領域的進步推動了這一趨勢，這些進步使得基於個別基因譜的治療成為可能，從而帶動了對標靶治療、改進診斷和精準醫療解決方案的需求。客製化基因檢測是這種方法的關鍵，它能夠提供詳細的基因訊息，用於準確評估疾病風險、制定個人化治療方案和預防性醫療保健策略。例如，美國非營利組織個人化醫療聯盟（Personalized Medicine Coalition）於2024年2月報告稱，美國食品藥物管理局）在2023年核准了16種用於治療罕見疾病患者的新型個人化療法。因此，個人化醫療的日益普及正在促進客製化基因檢測市場的擴張。

客製化基因檢測市場的主要企業正專注於面向消費者的直銷產品，尤其是居家DNA檢測與個人化醫療方案相結合的服務。居家DNA檢測允許個人在診所外採集唾液或口腔拭子樣本。通常，使用者在線上或在藥房訂購套件，然後將其郵寄至實驗室進行分析。例如，2025年5月，總部位於加拿大的數位健康技術公司Hydreight Technologies Inc.在其VSDHOne平台上推出了一項個人化基因檢測和健康服務。該服務提供便利的居家DNA檢測套組和客製化的健康方案，這些方案涵蓋營養、健身、補充劑和藥物相容性等方面。該平台還支援透過遠端醫療服務和與合格醫療保健專業人員的面對面預約進行持續護理。

2025年3月，總部位於美國的精準醫療公司Tempos收購了Ambry Genetics，但未揭露金額。此次收購旨在透過將Ambry在遺傳疾病診斷方面的經驗與Tempos的人工智慧主導精準醫療平台結合，增強Tempos的市場地位並擴展其基因組檢測能力。 Ambry Genetics同樣總部位於美國，是一家知名的臨床基因檢測服務提供商，專注於支援遺傳疾病診斷、癌症風險評估和精準醫療的次世代定序儀技術。

客製化基因檢測市場包括提供個人化檢測、診斷評估和客製化基因組報告等服務的營業單位所獲得的收入。市場價值還包括服務供應商提供的或與服務供應商捆綁銷售的相關商品的價值。此累計僅涵蓋營業單位間交換或直接銷售給最終消費者的商品和服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球客製化基因檢測：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球客製化基因檢測市場：成長率分析
  • 全球客製化基因檢測市場表現：規模與成長，2019-2024年
  • 全球客製化基因檢測市場預測：規模與成長，2024-2029年，2034年預測
  • 全球客製化基因檢測：潛在市場規模 (TAM)

第6章 市場細分

  • 全球客製化基因檢測市場依檢測類型、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 預測性測試
  • 載體測試
  • 產前和新生兒檢測
  • 診斷測試
  • 藥物基因組學檢測
  • 全球客製化基因檢測市場依樣本類型、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 唾液
  • 血
  • 口腔拭子
  • 全球客製化基因檢測市場：依技術、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 下一代定序（NGS）
  • 聚合酵素鏈鎖反應（PCR）
  • 微陣列分析
  • 單細胞定序
  • 全球客製化基因檢測市場：依應用、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 腫瘤學
  • 心血管疾病
  • 神經系統疾病
  • 代謝紊亂
  • 全球客製化基因檢測市場：依最終用戶分類，實際值及預測值，2019-2024年、2024-2029年預測值、2034年預測值
  • 醫院和診所
  • 診斷實驗室
  • 研究所
  • 全球客製化基因檢測市場：按檢測項目、類型、性能和預測進行細分，2019-2024年、2024-2029年預測、2034年預測
  • 癌症易感性檢測
  • 神經退化性疾病檢測
  • 心血管疾病風險檢測
  • 代謝紊亂風險測試
  • 全球客製化基因檢測市場：按帶因者檢測、類型、性能和預測進行細分，2019-2024年、2024-2029年預測、2034年預測
  • 囊腫纖維化帶原者檢測
  • 鐮狀細胞貧血帶因者檢測
  • 泰-薩克斯病帶因者檢測
  • 地中海貧血帶因者檢測
  • 全球客製化基因檢測市場：按產前和新生兒檢測、類型、性能和預測進行細分，2019-2024年、2024-2029年預測、2034年預測
  • 非侵入性產前檢測（NIPT）
  • 新生兒篩檢小組
  • 絨毛膜絨毛取樣（CVS）
  • 基於羊膜穿刺術的基因檢測
  • 全球客製化基因檢測市場：依診斷測試、類型、效能和預測細分，2019-2024年、2024-2029年預測、2034年預測
  • 罕見疾病診斷
  • 腫瘤基因檢測
  • 神經系統疾病診斷
  • 感染疾病相關基因檢測
  • 全球客製化基因檢測市場：依藥物基因體學檢測、類型、表現及預測細分，2019-2024年、2024-2029年預測、2034年預測
  • 藥物代謝試驗
  • 癌症藥物基因體學
  • 心血管藥物反應測試
  • 精神藥物檢測

第7章 區域和國家分析

  • 全球客製化基因檢測市場：依地區、績效及預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 全球客製化基因檢測市場：按國家、績效和預測分類，2019-2024 年、2024-2029 年預測、2034 年預測

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 客製化基因檢測市場：競爭格局
  • 客製化基因檢測市場：公司概況
    • Guardant Health Overview, Products and Services, Strategy and Financial Analysis
    • Tempus Overview, Products and Services, Strategy and Financial Analysis
    • Invitae Overview, Products and Services, Strategy and Financial Analysis
    • 23andMe Overview, Products and Services, Strategy and Financial Analysis
    • Labcorp Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Quest Diagnostics
  • Revvity Omics（PerkinElmer Genomics）
  • Natera
  • Myriad Genetics
  • BGI Genomics
  • CENTOGENE
  • Veracyte
  • Fulgent Genetics
  • LetsGetChecked
  • Helix
  • MedGenome
  • Baylor Genetics
  • Prenetics
  • Eurofins（Clinical Genetics）
  • Mapmygenome

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年客製化基因檢測市場：提供新機會的國家
  • 2029年客製化基因檢測市場：新興細分市場機會
  • 2029年客製化基因檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r38493

Customized genetic testing is a personalized method of genetic analysis that selects specific genes, variants, or DNA regions to examine based on an individual's unique needs, such as medical history, family health background, ethnicity, or particular clinical concerns. This testing targets the genes most relevant to the patient's situation, enabling more accurate risk assessment, diagnosis, and management. Customized genetic testing helps identify inherited conditions, guide treatment decisions, and support choices in areas such as disease prevention, reproductive planning, and personalized medicine.

The primary test types of customized genetic testing are predictive testing, carrier testing, prenatal and newborn testing, diagnostic testing, and pharmacogenomic testing. Predictive testing involves examining an individual's genetic makeup to evaluate the risk of developing specific hereditary conditions before symptoms appear. It is especially valuable for conditions that manifest later in life, allowing for early interventions and informed decision-making. Samples used include saliva, blood, and buccal swabs, which are analyzed using next-generation sequencing (NGS), polymerase chain reaction (PCR), microarray analysis, and single-cell sequencing technologies. Applications cover areas such as oncology, cardiovascular diseases, neurological disorders, and metabolic disorders, and are applied across predictive testing, carrier testing, prenatal and newborn testing, diagnostic testing, and pharmacogenomic testing.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The customized genetic testing market research report is one of a series of new reports from The Business Research Company that provides customized genetic testing market statistics, including customized genetic testing industry global market size, regional shares, competitors with a customized genetic testing market share, detailed customized genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the customized genetic testing industry. This customized genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The customized genetic testing market size has grown rapidly in recent years. It will grow from $12.16 billion in 2024 to $14.13 billion in 2025 at a compound annual growth rate (CAGR) of 16.2%. The growth during the historical period is attributed to the increased adoption of personalized medicine, a rise in genetic disorder cases, early incorporation of genetic testing in oncology and pharmacogenomics, improvements in sequencing technologies, and a growing consumer interest in ancestry and direct-to-consumer genetic testing.

The customized genetic testing market size is expected to rapid growth in the next few years. It will grow to $25.50 billion in 2029 at a compound annual growth rate (CAGR) of 15.9%. The forecast growth period is driven by the decreasing cost of whole genome sequencing, broader uses in preventive healthcare, government support for genomics research, the integration of artificial intelligence in genetic data analysis, and heightened collaboration between diagnostic firms and pharmaceutical companies for targeted therapies. Key trends anticipated include a move toward at-home genetic testing kits, increased attention to polygenic risk scoring, the creation of multi-omics-based personalized healthcare solutions, greater emphasis on genetic counseling services alongside testing, and the use of blockchain technology for secure management of genetic data.

The rising adoption of personalized medicine is expected to drive the growth of the customized genetic testing market in the coming years. Personalized medicine is a healthcare approach where treatments, preventive strategies, and medical decisions are tailored to the unique characteristics of each patient. This trend is supported by advancements in genomics, proteomics, and biomarker discovery, enabling treatments based on individual genetic profiles and increasing demand for targeted therapies, improved diagnostics, and precision healthcare solutions. Customized genetic testing is essential in this approach, offering detailed genetic insights for accurate disease risk assessment, personalized treatments, and preventive care strategies. For example, in February 2024, the Personalized Medicine Coalition, a US nonprofit organization, reported that the United States Food and Drug Administration approved 16 new personalized treatments for rare disease patients in 2023, up from six approvals in 2022. As a result, the growing adoption of personalized medicine is contributing to the expansion of the customized genetic testing market.

Key companies in the customized genetic testing market are focusing on direct-to-consumer offerings, particularly at-home DNA testing combined with health plans tailored to individual genetic information. At-home DNA testing allows individuals to collect saliva or cheek swab samples outside clinical settings, typically by ordering a kit online or from a pharmacy and mailing it to a laboratory for analysis. For example, in May 2025, Hydreight Technologies Inc., a digital health technology company based in Canada, launched a personalized genetic testing and wellness service on its VSDHOne Platform. The service offers convenient access to at-home DNA testing kits and delivers customized health plans addressing nutrition, fitness, supplementation, and medication compatibility. The platform also supports ongoing care through telehealth services and in-person consultations with licensed healthcare professionals.

In March 2025, Tempus, a precision medicine company based in the United States, acquired Ambry Genetics for an undisclosed amount. This acquisition aims to enhance Tempus' position in the market and expand its genomic testing capabilities by combining Ambry's experience in inherited disease diagnostics with Tempus' artificial intelligence-driven precision medicine platform. Ambry Genetics, also based in the United States, is a prominent provider of clinical genetic testing, specializing in inherited disease diagnostics, cancer risk assessment, and next-generation sequencing technologies that support precision healthcare.

Major players in the customized genetic testing market are Guardant Health, Tempus, Invitae, 23andMe, Labcorp, Quest Diagnostics, Revvity Omics (PerkinElmer Genomics), Natera, Myriad Genetics, BGI Genomics, CENTOGENE, Veracyte, Fulgent Genetics, LetsGetChecked, Helix, MedGenome, Baylor Genetics, Prenetics, Eurofins (Clinical Genetics), Mapmygenome, Nebula Genomics.

North America was the largest region in the customized genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in customized genetic testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the customized genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The customized genetic testing market includes revenues earned by entities by providing services such as personalized testing, diagnostic evaluations, and customized genomic reporting. The market value also includes the worth of related goods supplied by service providers or bundled within their offerings. Only goods and services exchanged between entities or sold directly to end consumers are accounted for in this valuation.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Customized Genetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on customized genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for customized genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The customized genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Predictive Testing; Carrier Testing; Prenatal And Newborn Testing; Diagnostic Testing; Pharmacogenomic Testing
  • 2) By Sample Type: Saliva; Blood; Buccal Swab
  • 3) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Microarray Analysis; Single-Cell Sequencing
  • 4) By Application: Oncology; Cardiovascular Diseases; Neurological Disorders; Metabolic Disorders
  • 5) By End-User: Predictive Testing; Carrier Testing; Prenatal And Newborn Testing; Diagnostic Testing; Pharmacogenomic Testing
  • Subsegments:
  • 1) By Predictive Testing: Cancer Susceptibility Testing; Neurodegenerative Disorder Testing; Cardiovascular Disease Risk Testing; Metabolic Disorder Risk Testing
  • 2) By Carrier Testing: Cystic Fibrosis Carrier Testing; Sickle Cell Anemia Carrier Testing; Tay-Sachs Disease Carrier Testing; Thalassemia Carrier Testing
  • 3) By Type Prenatal And Newborn Testing: Non-Invasive Prenatal Testing (NIPT); Newborn Screening Panels; Chorionic Villus Sampling (CVS); Amniocentesis-Based Genetic Testing
  • 4) By Diagnostic Testing: Rare Disease Diagnosis; Oncology Genetic Testing; Neurological Disorder Diagnosis; Infectious Disease-Associated Genetic Testing
  • 5) By Pharmacogenomic Testing: Drug Metabolism Testing; Oncology Pharmacogenomics; Cardiovascular Drug Response Testing; Psychiatric Drug Response Testing
  • Companies Mentioned: Guardant Health; Tempus; Invitae; 23andMe; Labcorp; Quest Diagnostics; Revvity Omics (PerkinElmer Genomics); Natera; Myriad Genetics; BGI Genomics; CENTOGENE; Veracyte; Fulgent Genetics; LetsGetChecked; Helix; MedGenome; Baylor Genetics; Prenetics; Eurofins (Clinical Genetics); Mapmygenome; Nebula Genomics
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Customized Genetic Testing Market Characteristics

3. Customized Genetic Testing Market Trends And Strategies

4. Customized Genetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Customized Genetic Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Customized Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Customized Genetic Testing Market Growth Rate Analysis
  • 5.4. Global Customized Genetic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Customized Genetic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Customized Genetic Testing Total Addressable Market (TAM)

6. Customized Genetic Testing Market Segmentation

  • 6.1. Global Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Predictive Testing
  • Carrier Testing
  • Prenatal And Newborn Testing
  • Diagnostic Testing
  • Pharmacogenomic Testing
  • 6.2. Global Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Saliva
  • Blood
  • Buccal Swab
  • 6.3. Global Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Microarray Analysis
  • Single-Cell Sequencing
  • 6.4. Global Customized Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Cardiovascular Diseases
  • Neurological Disorders
  • Metabolic Disorders
  • 6.5. Global Customized Genetic Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • 6.6. Global Customized Genetic Testing Market, Sub-Segmentation Of Predictive Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Susceptibility Testing
  • Neurodegenerative Disorder Testing
  • Cardiovascular Disease Risk Testing
  • Metabolic Disorder Risk Testing
  • 6.7. Global Customized Genetic Testing Market, Sub-Segmentation Of Carrier Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cystic Fibrosis Carrier Testing
  • Sickle Cell Anemia Carrier Testing
  • Tay-Sachs Disease Carrier Testing
  • Thalassemia Carrier Testing
  • 6.8. Global Customized Genetic Testing Market, Sub-Segmentation Of Prenatal And Newborn Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Non-Invasive Prenatal Testing (NIPT)
  • Newborn Screening Panels
  • Chorionic Villus Sampling (CVS)
  • Amniocentesis-Based Genetic Testing
  • 6.9. Global Customized Genetic Testing Market, Sub-Segmentation Of Diagnostic Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rare Disease Diagnosis
  • Oncology Genetic Testing
  • Neurological Disorder Diagnosis
  • Infectious Disease-Associated Genetic Testing
  • 6.10. Global Customized Genetic Testing Market, Sub-Segmentation Of Pharmacogenomic Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Metabolism Testing
  • Oncology Pharmacogenomics
  • Cardiovascular Drug Response Testing
  • Psychiatric Drug Response Testing

7. Customized Genetic Testing Market Regional And Country Analysis

  • 7.1. Global Customized Genetic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Customized Genetic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Customized Genetic Testing Market

  • 8.1. Asia-Pacific Customized Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Customized Genetic Testing Market

  • 9.1. China Customized Genetic Testing Market Overview
  • 9.2. China Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Customized Genetic Testing Market

  • 10.1. India Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Customized Genetic Testing Market

  • 11.1. Japan Customized Genetic Testing Market Overview
  • 11.2. Japan Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Customized Genetic Testing Market

  • 12.1. Australia Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Customized Genetic Testing Market

  • 13.1. Indonesia Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Customized Genetic Testing Market

  • 14.1. South Korea Customized Genetic Testing Market Overview
  • 14.2. South Korea Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Customized Genetic Testing Market

  • 15.1. Western Europe Customized Genetic Testing Market Overview
  • 15.2. Western Europe Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Customized Genetic Testing Market

  • 16.1. UK Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Customized Genetic Testing Market

  • 17.1. Germany Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Customized Genetic Testing Market

  • 18.1. France Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Customized Genetic Testing Market

  • 19.1. Italy Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Customized Genetic Testing Market

  • 20.1. Spain Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Customized Genetic Testing Market

  • 21.1. Eastern Europe Customized Genetic Testing Market Overview
  • 21.2. Eastern Europe Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Customized Genetic Testing Market

  • 22.1. Russia Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Customized Genetic Testing Market

  • 23.1. North America Customized Genetic Testing Market Overview
  • 23.2. North America Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Customized Genetic Testing Market

  • 24.1. USA Customized Genetic Testing Market Overview
  • 24.2. USA Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Customized Genetic Testing Market

  • 25.1. Canada Customized Genetic Testing Market Overview
  • 25.2. Canada Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Customized Genetic Testing Market

  • 26.1. South America Customized Genetic Testing Market Overview
  • 26.2. South America Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Customized Genetic Testing Market

  • 27.1. Brazil Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Customized Genetic Testing Market

  • 28.1. Middle East Customized Genetic Testing Market Overview
  • 28.2. Middle East Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Customized Genetic Testing Market

  • 29.1. Africa Customized Genetic Testing Market Overview
  • 29.2. Africa Customized Genetic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Customized Genetic Testing Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Customized Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Customized Genetic Testing Market Competitive Landscape And Company Profiles

  • 30.1. Customized Genetic Testing Market Competitive Landscape
  • 30.2. Customized Genetic Testing Market Company Profiles
    • 30.2.1. Guardant Health Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Tempus Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Invitae Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. 23andMe Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Labcorp Overview, Products and Services, Strategy and Financial Analysis

31. Customized Genetic Testing Market Other Major And Innovative Companies

  • 31.1. Quest Diagnostics
  • 31.2. Revvity Omics (PerkinElmer Genomics)
  • 31.3. Natera
  • 31.4. Myriad Genetics
  • 31.5. BGI Genomics
  • 31.6. CENTOGENE
  • 31.7. Veracyte
  • 31.8. Fulgent Genetics
  • 31.9. LetsGetChecked
  • 31.10. Helix
  • 31.11. MedGenome
  • 31.12. Baylor Genetics
  • 31.13. Prenetics
  • 31.14. Eurofins (Clinical Genetics)
  • 31.15. Mapmygenome

32. Global Customized Genetic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Customized Genetic Testing Market

34. Recent Developments In The Customized Genetic Testing Market

35. Customized Genetic Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Customized Genetic Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Customized Genetic Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Customized Genetic Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer